Access cutting-edge early-onset alzheimer disease treatment through this phase 1 clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this La Jolla location
Preparing your pre-screening questions…
Access early-onset alzheimer disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related early-onset alzheimer disease treatment provided free
Check if you qualify for this early-onset alzheimer disease clinical trial in La Jolla, CA
No-Cost Study Care
Local to La Jolla
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-APP administered by intrathecal (IT) injection in adult patients with early-onset Alzheimer's Disease (EOAD). Maximum treatment duration for Part A: single dose. Maximum treatment duration for Part B: 12 months.
Sponsor: Alnylam Pharmaceuticals
Yes, this clinical trial (NCT05231785) has an active research site in La Jolla, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for early-onset alzheimer disease treatment options in La Jolla, CA, this clinical trial (NCT05231785) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced early-onset alzheimer disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all early-onset alzheimer disease clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in La Jolla — not just this study.
Browse Alzheimers Disease Trials in La Jolla →